Danaher Corporation

Danaher is a science and technology conglomerate focused on life sciences, diagnostics and biotechnology, supplying instruments, reagents and consumables to laboratories, hospitals and drug makers. It is known for the Danaher Business System, a disciplined operating and acquisition playbook that has compounded value across a portfolio of high-margin, recurring-revenue businesses. Danaher has raised its dividend for over two decades, though it deliberately keeps the yield low to prioritise reinvestment and bolt-on acquisitions. Income here is secondary to capital growth, but the long record of increases and strong, stable cash flows give the payout a dependable character. The solid score reflects quality and consistency rather than headline yield.